Access cutting-edge kidney cancer treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.
Access kidney cancer specialists in Aurora at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney cancer treatment provided free
This is a Phase Ib/III, randomized, multicenter, global study evaluating the efficacy and safety of volrustomig in combination with casdatifan for the first-line (1L) treatment of participants with advanced clear cell renal cell carcinoma (ccRCC).
Sponsor: AstraZeneca
Check if you qualify for this kidney cancer clinical trial in Aurora, CO
If you're searching for kidney cancer treatment options in Aurora, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.